Keros Therapeutics, Inc. logo KROS - Keros Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 7
SELL 0
STRONG
SELL 0
| PRICE TARGET: $102.60 DETAILS
HIGH: $107.00
LOW: $96.00
MEDIAN: $105.00
CONSENSUS: $102.60
UPSIDE: 811.19%

Profitability Ratios

Ratio Value
GP Margin 99.4%
EBIT Margin 37.7%
EBITDA Margin 38.3%
Operating Margin 28.9%
Pretax Margin 37.7%
Cont. Ops Margin 35.7%
Net Margin 35.7%
Bottom Line Margin 35.7%

Liquidity Ratios

Ratio Value
Current Ratio 15.45
Quick Ratio 15.45
Solvency Ratio 2.537
Cash Ratio 14.08

Valuation Ratios

Ratio Value
Price/Earnings
8.70
Hist. avg: 8.7
Peers avg: 33.6
PEG Ratio -0.06
Forward PEG -0.06
Price/Book 2.50
Price/Sales 3.11
Price/FCF 7.15
Price/Op Cash Flow 7.05

Debt Ratios

Ratio Value
Debt/Assets 0.0499
Debt/Equity 0.0557
Debt/Capital 0.0528
Long-Term Debt/Capital 0.0000
Financial Leverage 1.12

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.57
Operating Cash Flow Ratio 5.266
Operating Cash Flow/Sales 44.0%
Free Cash Flow/Operating Cash Flow 98.6%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 6.37
Capital Expenditure Coverage 69.31
Dividend + Capital Expenditure Coverage 69.31

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 6.56
EPS 2.338
Debt/Share 0.4536
Cash/Share 7.72
Book Value/Share 8.14
Tangible BV/Share 8.14
Equity/Share 8.14
Operating Cash Flow/Share 2.888
Capital Expenditure/Share 0.042
FCF/Share 2.847

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.947
Earnings Before Tax/EBIT 1.301
Price/Fair Value 2.50
Debt/Market Cap 0.0000
Effective Tax Rate 5.3%
Enterprise Value Multiple 5.22